Alzheimer's Disease Trial, Recruiting NCT05558709 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT05558709
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients:

  • People aged between 18 and 90 years old
  • People who score 20 or above on a standard memory and thinking test called the MMSE
  • People who are able to clearly and independently express that they are willing to take part in the study
  • People who have been diagnosed with a neurodegenerative condition, specifically frontotemporal dementia (FTD), Alzheimer's disease (AD), or Lewy body dementia (LBD)

For caregivers:

  • People aged 18 or older
  • People who have regular contact with the patient, meaning at least twice a month

Who may not be able to join:

For patients:

  • People who have another neurological or psychiatric condition in addition to their dementia diagnosis
  • People who have significant sensory difficulties — such as severe or total hearing loss, age-related macular degeneration, or blindness — that could interfere with completing the study tasks
  • People who do not wish to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marc VERNY, Pr, Assistance Publique - Hôpitaux de Paris

Phone: 01 42 16 03 12

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
4 February 2026
Est. completion
4 February 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

rate of inappropriate behavioural intentions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov